These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 18709691

  • 1. Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis.
    Antonelli A, Ferri C, Fallahi P, Colaci M, Giuggioli D, Ferrari SM, Frascerra S, Franzoni F, Galetta F, Ferrannini E.
    J Rheumatol; 2008 Sep; 35(9):1809-11. PubMed ID: 18709691
    [Abstract] [Full Text] [Related]

  • 2. CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study.
    Antonelli A, Ferri C, Fallahi P, Ferrari SM, Giuggioli D, Colaci M, Manfredi A, Frascerra S, Franzoni F, Galetta F, Ferrannini E.
    Rheumatology (Oxford); 2008 Jan; 47(1):45-9. PubMed ID: 18077490
    [Abstract] [Full Text] [Related]

  • 3. High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis.
    Antonelli A, Fallahi P, Delle Sedie A, Ferrari SM, Maccheroni M, Bombardieri S, Riente L, Ferrannini E.
    Autoimmunity; 2008 Nov; 41(7):537-42. PubMed ID: 18855195
    [Abstract] [Full Text] [Related]

  • 4. Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis.
    Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Carpi A, Nicolini A, Ferrannini E.
    Metabolism; 2008 Sep; 57(9):1270-7. PubMed ID: 18702954
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
    Fujii H, Shimada Y, Hasegawa M, Takehara K, Sato S.
    J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
    [Abstract] [Full Text] [Related]

  • 6. CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C.
    Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Franzoni F, Galetta F, Zignego AL, Ferrannini E.
    Dig Liver Dis; 2009 Jan; 41(1):42-8. PubMed ID: 18760981
    [Abstract] [Full Text] [Related]

  • 7. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study.
    Antonelli A, Fallahi P, Ferrari SM, Pupilli C, d'Annunzio G, Lorini R, Vanelli M, Ferrannini E.
    Diabet Med; 2008 Nov; 25(11):1349-53. PubMed ID: 19046227
    [Abstract] [Full Text] [Related]

  • 8. Th1 (CXCL10) and Th2 (CCL2) chemokine expression in patients with immune thrombocytopenia.
    Gu D, Chen Z, Zhao H, Du W, Xue F, Ge J, Sui T, Wu H, Liu B, Lu S, Zhang L, Yang R.
    Hum Immunol; 2010 Jun; 71(6):586-91. PubMed ID: 20153790
    [Abstract] [Full Text] [Related]

  • 9. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
    Antonelli A, Fallahi P, Ferrari SM, Giuggioli D, Colaci M, Di Domenicantonio A, Ferri C.
    J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
    [Abstract] [Full Text] [Related]

  • 10. High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis.
    Antonelli A, Fallahi P, Delle Sedie A, Ferrari SM, Maccheroni M, Bombardieri S, Riente L, Ferrannini E.
    Clin Exp Rheumatol; 2009 May; 27(1):22-7. PubMed ID: 19327225
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
    Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S.
    J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
    [Abstract] [Full Text] [Related]

  • 12. Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
    Carulli MT, Handler C, Coghlan JG, Black CM, Denton CP.
    Ann Rheum Dis; 2008 Jan; 67(1):105-9. PubMed ID: 17604287
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P.
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [Abstract] [Full Text] [Related]

  • 14. High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis.
    Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Sebastiani M, Franzoni F, Galetta F, Ferrannini E.
    Cytokine; 2008 Apr; 42(1):137-43. PubMed ID: 18282714
    [Abstract] [Full Text] [Related]

  • 15. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides.
    Shimauchi T, Sugita K, Nishio D, Isoda H, Abe S, Yamada Y, Hino R, Ogata M, Kabashima K, Tokura Y.
    J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665
    [Abstract] [Full Text] [Related]

  • 16. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A, Ferri C, Fallahi P, Ferrari SM, Sebastiani M, Ferrari D, Giunti M, Frascerra S, Tolari S, Franzoni F, Galetta F, Marchi S, Ferrannini E.
    Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
    [Abstract] [Full Text] [Related]

  • 17. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
    Moreira MA, Tilbery CP, Monteiro LP, Teixeira MM, Teixeira AL.
    Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
    [Abstract] [Full Text] [Related]

  • 18. Serum CXCL10 levels and neuromuscular manifestations in patients with autoimmune thyroid diseases.
    Cakir M, Levendoglu F, Kiyici A, Coskun Y.
    Autoimmunity; 2011 Sep; 44(6):496-503. PubMed ID: 21457060
    [Abstract] [Full Text] [Related]

  • 19. Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis.
    Morimoto S, Tokano Y, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Suzuki J, Kaneko H, Sekigawa I, Takasaki Y.
    Autoimmunity; 2009 Feb; 42(2):143-9. PubMed ID: 19021013
    [Abstract] [Full Text] [Related]

  • 20. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I, Hasegawa M, Takehara K, Sato S.
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.